Skip to content

Clinical Study of Guijiangxiancha Formula on Overweight/Obesity Patients with Yang Deficiency of Spleen and Kidney

Clinical Study of Guijiangxiancha Formula on Overweight/Obesity Patients with Yang Deficiency of Spleen and Kidney

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2023000002
Enrollment
Unknown
Registered
2023-03-22
Start date
2023-04-01
Completion date
Unknown
Last updated
2023-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Overweight/Obesity

Interventions

Control group:Health education+Routine dietary guidance
Experimental group:Health education+Routine dietary guidance+Guijiangxiancha Formula

Sponsors

Xiyuan Hospital of China Academy of Chinese Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1)Cases meet the Western diagnostic criteria for overweight/obesity; (2)Cases neet the TCM syndrome differentiation standards; (3)Patients between the ages of 18 and 65 years , of either sex. (4)Volunteering to participate in this trial ,Willing to cooperate with treatment and Signing informed consent form. )

Exclusion criteria

Exclusion criteria: (1)Cases of secondary obesityserious complications of obesity-related diseasesmalignant tumors, severe heart diseases, serious blood system diseases; (2)Patients with anemia or abnormal hemoglobin levels; (3)Patients with liver and kidney insufficiency or infectious diseases; (4)Syndrome differentiation of TCM is blood deficiency without qi stagnation and blood stasis; (5)Patients have taken weight loss drugs in the past three months; (6)Patients who are allergic to the composition of the test drug prescription; (7)Patients with previous or current serious mental illness. (8) Pregnancy, prepare to pregnant in recent three months or in lactation; (9)Participated in other clinical trials in recent one month or currently join another tria. (10)The researchers think it is not appropriate for clinical participants.

Design outcomes

Primary

MeasureTime frame
Weight;Syndrome score of TCM;

Secondary

MeasureTime frame
TG;HOMA-IR;Infrared thermal imaging map;HOMA-ß;Waist circumference;TC;LDL-C;Hip circumference;FINS;Human body composition analysis;IAI;FPG;HDL-C;TNF-a;

Countries

China

Contacts

Public ContactZhang Jin

Xiyuan Hospital of China Academy of Chinese Medical Sciences

13911893296@163.com+8613911893296

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026